Ge Long Hui A P P·2026-01-27 15:10Core Viewpoint - *ST San Sheng (002742.SZ) expects a net profit attributable to shareholders of the listed company to be between -530 million and -380 million yuan for 2025, with an operating income projected between 910 million and 1.07 billion yuan [1] Group 1: Financial Performance - The construction materials and pharmaceutical sectors experienced varying degrees of decline due to tight funding and changes in the external market environment [1] - The net profit after deducting non-recurring gains and losses is expected to be between -520 million and -360 million yuan [1] - The company's operating revenue is forecasted to be between 910 million and 1.07 billion yuan [1] Group 2: Debt and Liabilities - The company's restructuring plan does not exempt subsidiaries from joint liability guarantees for their borrowings, and related debts will be handled according to the restructuring plan [1] - The company has recognized estimated liabilities for potential guarantee losses based on the prudence principle of accounting standards [1] Group 3: Asset Impairment - The company has made provisions for impairment losses on assets based on the actual operating conditions of the pharmaceutical company and changes in the industry market [1]